Dr. Andreopoulou is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1283 York Avenue
New York, NY 10065
Summary
- I am a Professor of Medicine and the Director of Breast Cancer Clinical Research at Weill Cornell Medicine/NewYork-Presbyterian Hospital where I specialize in the personalized multidisciplinary care and treatment of patients with breast cancer. I am also a member of the Englander Institute for Precision Medicine at Cornell. I previously held faculty positions at the Albert Einstein College of Medicine/ Montefiore Medical Center and the University of Texas M.D. Anderson Cancer Center. I completed my training in major academic institutions in both Europe and the U.S., including St Bartholomew’s Hospital and the Royal Marsden Hospital/Institute of Cancer Research in London, UK and the New York University School of Medicine. I was a European Society of Medical Oncology fellow. I have a special interest in individualization of patient treatment and particularly in caring for women with aggressive breast cancer. My main research interest involves precision medicine to fast-track the drug development of biologics and targeted therapy that exploit our knowledge of the cancer genome and the immuno cell network for immunotherapy in order to effectively manage, treat and cure breast cancer. I am involved with all phases of clinical drug development in all stages of the disease and I especially focus on innovative clinical trial design that incorporates cutting-edge technology.
Education & Training
- NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 2005 - 2008
- NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 2006 - 2007
- University of Ioannina Faculty of MedicineClass of 1994, MD, Cum Laude
Certifications & Licensure
- NY State Medical License 2007 - 2026
- TX State Medical License 2008 - 2011
- ECFMG
Awards, Honors, & Recognition
- Assistant Professor of Medicine, Department of Breast Medical Oncology UT. MD Anderson Cancer Center, 2007-2010
- European Society of Medical Oncology (ESMO) Fellowship Royal Marsden Hospital/ Institute of Cancer Research, London, England
Clinical Trials
- Veliparib and Carboplatin in Treating Patients With HER2-Negative Metastatic Breast Cancer Start of enrollment: 2010 Nov 16
- Cyclophosphamide and Veliparib in Treating Patients With Locally Advanced or Metastatic Breast Cancer Start of enrollment: 2011 May 02
- A Phase III Study of BKM120 With Fulvestrant in Patients With HR+,HER2-, AI Treated, Locally Advanced or Metastatic Breast Cancer Who Progressed on or After mTORi Start of enrollment: 2012 Oct 03
- Join now to see all
Publications & Presentations
PubMed
- 51 citationsPegylated liposomal doxorubicin HCL (PLD; Caelyx/Doxil®): Experience with long-term maintenance in responding patients with recurrent epithelial ovarian cancerEleni Andreopoulou, D Gaiotti, E Kim, Andrea Downey, Deepu Mirchandani
Annals of Oncology. 2007-04-01 - 10 citationsResidual Pure Intralymphatic Breast Carcinoma Following Neoadjuvant Chemotherapy Is Indicative of Poor Clinical Outcome, Even in Node-Negative Patients.Esther Cheng, David Ko, Michaela Nguyen, Tracy-Ann Moo, Eleni Andreopoulou
The American Journal of Surgical Pathology. 2017-09-01 - 463 citationsA Genomic Predictor of Response and Survival Following Taxane-Anthracycline Chemotherapy for Invasive Breast CancerChristos Hatzis, Lajos Pusztai, Vicente Valero, Daniel J. Booser, Laura J. Esserman
JAMA. 2011-05-11
Press Mentions
- Efficacy of Margetuximab vs Trastuzumab in Patients with Pretreated ERBB2-Positive Advanced Breast CancerJanuary 22nd, 2021
- EMBCA Presents Evolution of Pharma and Biotech Industry in the 21st CenturyNovember 23rd, 2019
- One-Way Texting: No Help with Breast Cancer Pill Taking, But…July 25th, 2019
Professional Memberships
- Member
Other Languages
- Greek
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: